At the 2026 New England Institute of Ambulatory Care Pharmacists (NEIAP) Annual Forum, Jennifer Goldman detailed how monitoring data drive engagement—and how a new dual sensor readies pharmacists for ketone alerts.
|Videos|July 18, 2017
How Can Community Pharmacists Advance the Profession?
In this clip, Stefanie Ferreri, PharmD, clinical professor at UNC Eshelman School of Pharmacy, talks about how community pharmacists can work to advance the profession and change how community pharmacy is portrayed.
Advertisement
In this clip, Stefanie Ferreri, PharmD, clinical professor at UNC Eshelman School of Pharmacy, talks about how community pharmacists can work to advance the profession and change how community pharmacy is portrayed.
Advertisement
Related to this article
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
New European Respiratory Society (ERS) update makes sotatercept a strong add-on recommendation, opening a fourth pathway for pharmacists to manage.
A prospective observational study found microplastics more frequently and at higher levels in lung samples from patients with lung malignancies, although the findings do not establish that the particles cause cancer.
With nearly 8 in 10 older adults misusing at least 1 OTC product, clearer counseling and labels could close the gap.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
Contraceptive access gaps driven by federal rollbacks, provider shortages, and stalled state legislation could be narrowed by letting trained pharmacists prescribe birth control independently.
Cancer diagnoses among civilians exposed to 9/11 dust keep rising, with strained health programs struggling to meet growing needs.
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Overcome PCSK9 Inhibitor Access Barriers
2
From Reactive to Proactive: AI's Role in Modern Pharmacy Safety
3
Trial Ended Early When Venetoclax Plus DA-EPOCH-R Did Not Improve Outcomes in Double-Hit Lymphoma
4
Utilizing 340B Margin to Create a Patient Prescription Assistance Program
5